Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Mammotome secures CE mark for HydroMARK Plus, expanding breast biopsy marker access in Europe.
DHR
$200.30
+$0.64 +0.32%

Mammotome secures CE mark for HydroMARK Plus, expanding breast biopsy marker access in Europe.

Market News
04 Jun 2026
PRNewsWire
View Source
Bullish
pluang ai news

Mammotome, a Danaher company, has received the CE mark for its HydroMARK™ Plus Breast Biopsy Site Marker. This approval allows wider access to the innovative marker technology across Europe, benefiting patients undergoing breast cancer diagnosis and treatment. The HydroMARK Plus combines proprietary hydrogel technology with features that enhance marker stability and visibility in breast care, supporting improved clinical outcomes.

More News (DHR)

Danaher names Julie Sawyer Montgomery as new CEO, replacing retiring Rainer Blair on Oct 1, 2026

Danaher names Julie Sawyer Montgomery as new CEO, replacing retiring Rainer Blair on Oct 1, 2026

Danaher Corporation announced that Julie Sawyer Montgomery will become President and CEO starting October 1, 2026, succeeding Rainer Blair who will retire and serve as senior advisor until March 2027. Sawyer Montgomery has significantly grown Danaher...

Company Fundamentals
Bullish
3 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App